Abstract：
The Da Vinci single port® (SP) robotic platform heralds a new era of minimally invasive surgery (MIS). The primary objective of this study was to assess short-term outcomes in patients undergoing SP robotic hysterectomy with concomitant sacrocolpopexy for pelvic organ prolapse (POP). We performed a retrospective case series at two tertiary care centers between January 2021 and August 2023. Patients with POP electing to undergo SP robotic hysterectomy with concomitant sacrocolpopexy were included. Chart abstraction was used to collect patient demographics and clinical outcomes. Recurrent POP was defined as new bothersome vaginal bulge symptoms and evidence of POP beyond the hymen on postoperative examination. 69 patients were included. Median operative time was 209 min (135-312) and estimated blood loss was 100 mL (20-2000). 1 (1.4%) patient sustained a major vascular injury resulting in laparotomy. Median pain score and morphine equivalents administered in PACU were low at 3 (0-7) and 3.2 (0-27) respectively. At 3 months, 60 (86.9%) patients were seen either in person or via telemedicine for their follow up appointment. 59/60 (98.3%) reported no vaginal bulge symptoms and 50/51 (98.0%) had stage 0 or 1 prolapse on exam. One (1.4%) patient had recurrent prolapse and underwent an additional repair. Postoperative complications included 2 (2.9%) cases of ileus/small bowel obstruction, 1 (1.4%) pelvic hematoma requiring a blood transfusion, and 1 (1.4%) umbilical hernia. The SP robotic platform is a safe and feasible platform for MIS hysterectomy and sacrocolpopexy with good short term anatomic and symptomatic outcomes.
摘要：
达芬奇单端口®（SP）机器人平台预示着微创手术（MIS）的新时代。这项研究的主要目的是评估接受SP机器人子宫切除术并伴有sc结直肠切除术治疗盆腔器官脱垂（POP）的患者的短期预后。我们在2021年1月至2023年8月期间在两个三级护理中心进行了回顾性病例系列研究。包括选择接受SP机器人子宫切除术并伴随骶结肠结肠切除术的POP患者。图表抽象用于收集患者的人口统计学和临床结果。复发性POP被定义为新的令人烦恼的阴道隆起症状，以及术后检查处女膜以外的POP证据。包括69名患者。中位手术时间为209分钟（135-312），估计失血量为100mL（20-2000）。1例（1.4％）患者遭受了主要的血管损伤，导致剖腹手术。PACU中的中位疼痛评分和吗啡当量分别为3（0-7）和3.2（0-27）。3个月时,60例（86.9％）患者被亲自或通过远程医疗进行随访。59/60（98.3％）报告无阴道隆起症状，50/51（98.0％）在检查时出现0或1期脱垂。一名（1.4％）患者复发性脱垂并接受了额外的修复。术后并发症包括2例(2.9%)肠梗阻/小肠梗阻,1例（1.4％）需要输血的盆腔血肿，1（1.4%）脐疝。SP机器人平台是一个安全可行的MIS子宫切除术和骶结肠切除术平台，具有良好的短期解剖和症状性结果。
